Joint Formulary & PAD

Chlorhexidine with neomycin - Nasal staphylococci eradication

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Nasal cream
Associated Icons :
Restrictions / Comments :
Important
0.1% or 0.5% nasal cream. May contain Arachis oil. To check formulation prior to use in patients with a history of peanut allergy. Not for routine use in primary care. Follow advice in CKS

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Chlorhexidine with neomycin
Indication :
Nasal staphylococci eradication
Group Name :
Keywords :
meticillin resistant staphylococcus aureus, MRSA
Brand Names Include :
Naseptin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Chlorhexidine with neomycin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Nasal staphylococci eradication.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.